QIAGEN announced the appointment of Thomas Ebeling as a member of the Supervisory Board with immediate effect. Mr. Ebeling joins QIAGEN as part of a process launched by the Supervisory Board in 2020 to further complement and enhance the Board’s already extensive experience in Life Sciences and diagnostics. The addition of Mr. Ebeling brings the number of current Supervisory Board members to eight. Mr. Ebeling has been an advisor in recent years to various businesses after having served as the CEO of ProSiebenSat.1 Media from 2009 to 2018. Prior to that, he worked for Novartis from 1997 to 2008, including roles as CEO of Novartis Pharmaceuticals and also as CEO of Novartis Consumer Health. He began his career in 1987 and held various positions in marketing and sales in the consumer goods industry before joining Novartis.